EBV-Positive DLBCL, Nos
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14776 | Camrelizumab | 1 / 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 1 / 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
DB00635 | Prednisone | 1 / 2 | Recruiting | 1 |
DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
DB14765 | Rivoceranib | 1 / 2 | Recruiting | 1 |
DB14922 | Tislelizumab | 1 / 2 | Recruiting | 1 |
DB15043 | Toripalimab | 1 / 2 | Recruiting | 1 |
DB00541 | Vincristine | 1 / 2 | Recruiting | 1 |
DB11703 | Acalabrutinib | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 2 |
DB00997 | Doxorubicin | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB16582 | Lisocabtagene maraleucel | 2 | Recruiting | 1 |
DB15419 | Nanatinostat | 2 | Recruiting | 1 |
DB00860 | Prednisolone | 2 | Recruiting | 1 |
DB00073 | Rituximab | 2 | Recruiting | 1 |
DB15765 | Sintilimab | 2 | Recruiting | 1 |
DB14922 | Tislelizumab | 2 | Recruiting | 1 |
DB01610 | Valganciclovir | 2 | Recruiting | 1 |
DB00541 | Vincristine | 2 | Recruiting | 1 |
DB15035 | Zanubrutinib | 2 | Recruiting | 1 |